Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the 3rd Quarter ended 31st December, 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 24 2025
- Closure of Trading Window
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 06 2025
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And PharmaceuticalsLimited Held Today I.E. Saturday, December 06, 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 05 2025
Later from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Mar 26 2026
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 03 2026
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 23 2026
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 30 2026
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals